Molecular Diagnostics
News on lab-developed tests and emerging diagnostic technologies.
Personalis, Tempus Partner to Commercialize Blood-Based Minimal Residual Disease Test
Tempus will market Personalis' NeXT Personal Dx liquid biopsy while Personalis completes its clinical validation in more indications.
Quest Diagnostics, Scipher Medicine Collaborate on Rheumatoid Arthritis Test
Quest will provide RNA extraction and sequencing services for Scipher's PrismRA test, a blood-based molecular test for predicting patient response to TNF inhibitors.
Germany to Test Genomics-Based Precision Medicine for Cancer, Rare Disease in National Pilot Project
Premium
With reimbursement from public health insurance, the "model project" will run for at least five years and examine the utility of genomic sequencing for advanced cancer and rare disease patients.
GenDx, OSE Immunotherapeutics Ink Deal to Develop NGS CDx for Epitope-Based Cancer Vaccine
Under the deal, GenDx will develop and validate a companion diagnostic test for high-resolution typing of HLA-A*02 based on its IVDR-registered NGS products.
Cardio Diagnostics Publishes Validation Data for Molecular Coronary Heart Disease Test
The new study in the Journal of the American Heart Association shows that the firm's machine learning-based genetic-epigenetic approach can help diagnose coronary heart disease.